ALYSON ADAMS: Open Payments
NPI 1477820462 · LANCASTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 30 payments from 7 companies in 2025. Trend: 2023 $798 · 2024 $265 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $151 |
| PFIZER INC. | 7 | $140 |
| Novartis Pharmaceuticals Corporation | 6 | $109 |
| Novo Nordisk Inc | 2 | $28 |
| ABIOMED | 1 | $27 |
| Mannkind Corporation | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: REPATHA, LEQVIO, ELIQUIS, VYNDAQEL, Wegovy, AFREZZA, NEXLETOL.
Industry payments across OH — which companies pay providers there.
